oral efficacy of sermorelin ipamorelin cjc 1295 CJC-1295 and Sermorelin: The Power Duo for Growth Hormone Release Comment “curious” for the full
Description
IQR: 4.513.16) diagnosed with malignant (74%) or non-malignant diseases (26%) received 864 mDLI infusions, administered either as needed or as a prophylactic regimen
doi: 10.1016/j.cca.2019.07.037
Ipamorelin is a pentapeptide compound and a growth hormone releasing peptide that functions as a selective growth hormone secretagogue (National Library of Medicine), stimulating the pituitary gland to release more human growth hormones
El-Hammadi MM, Arias JL
